// App-Quantinova.ai

3101 : The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model

Researchers

Presenter

  • Yukino Machida

Principal Investigators

  • Yoko Ogawara

  • Koichi Ichimura

  • Hironori Matsunaga

  • Seki Takahiko

  • Kazushi Araki

  • Issay Kitabayashi

Medical Centers

  • National Cancer Center Research Institute, Tokyo, Japan

  • Daiichi-Sankyo, Tokyo, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Glioblastoma

  • Solid malignancies

  • Gliomas

  • Thymomas

Biomarkers

  • Isocitrate dehydrogenase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved